Status:
UNKNOWN
Pacing the Atrium to Confirm or Exclude Pacemaker Indication in TAVI
Lead Sponsor:
AZ Sint-Jan AV
Conditions:
Aortic Valve Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
The current observational registry aims to evaluate in patients undergoing TAVI implantation: 1. the positive and negative predictive value for PPM post TAVI of Wenckebach phenomenona (WB) during RAP...
Detailed Description
The persistent growth in transcatheter aortic valve implantation (TAVI) calls for optimized early discharge programs to handle the increasing patient load. While access site bleeding and stroke rate h...
Eligibility Criteria
Inclusion
- All patients in sinus rhythm with TAVI
Exclusion
- Patients in atrial fibrillation at the time of the implantation
- Patients with pre-existent pacemaker
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05278585
Start Date
September 1 2022
End Date
June 1 2024
Last Update
November 29 2023
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Algemeen Stedelijk Ziekenhuis Aalst
Aalst, Belgium
2
OLV Aalst
Aalst, Belgium
3
ZNA Middelheim
Antwerp, Belgium
4
AZ Sint Jan
Bruges, Belgium, 8000